Results 41 to 50 of about 31,308 (159)

MYASTHENIA GRAVIS [PDF]

Brain, 1900
n ...
Campbell, Harry, Bramwell, Edwin
openaire   +2 more sources

Consistent improvement with eculizumab across muscle groups in myasthenia gravis

Annals of Clinical and Translational Neurology, 2020
Objective To assess whether eculizumab, a terminal complement inhibitor, improves patient‐ and physician‐reported outcomes (evaluated using the myasthenia gravis activities of daily living profile and the quantitative myasthenia gravis scale ...
Renato Mantegazza, Fanny L. O'Brien, Marcus Yountz, James F. Howard Jr, for the REGAIN study group   +4 more
doaj   +1 more source

Identification of metabolic biomarkers and therapeutic targets in the thymoma-associated myasthenia gravis treated with methylprednisolone

Discover Oncology
Objective This study aims to screen and identify metabolic biomarkers and targets for methylprednisolone treatment of thymoma with myasthenia gravis (MG) through metabolomics and network pharmacology analysis, thereby improving guidance for clinical ...
Shanshan Gu, Xu Wang, Hongxia Yang, Yaxuan Wang, Congya Yan, Xiaoting Lin, Peng Liu, Lu Liu, Li Meng, Guoyan Qi   +9 more
doaj   +1 more source

Determinants of quality of life in Brazilian patients with myasthenia gravis

Clinics
OBJECTIVES: The aims of the current study were 1) to evaluate the reliability and validity of the Brazilian version of the 15-item Myasthenia Gravis Quality of Life Scale and 2) to investigate the quality of life of Brazilian patients with myasthenia ...
Aline Mansueto Mourão, Rodrigo Santiago Gomez, Luiz Sergio Mageste Barbosa, Denise da Silva Freitas, Elizabeth Regina Comini-Frota, Arthur Kummer, Stella Maris Aguiar Lemos, Antonio Lucio Teixeira   +7 more
doaj   +1 more source

The prognosis of MG patients with different thymic pathology: a multicenter retrospective cohort study

BMC Medicine
Background To identify the associations between thymic pathology and the prognosis of myasthenia gravis (MG) patients. Methods In this multicenter retrospective study, 1,254 myasthenia gravis (MG) patients who underwent thymectomy across four clinical ...
Moli Fan, Hao Zhang, Yutong Shi, Xiaoyu Huang, Ying Cui, Zihao Yu, Xiao-He Zhang, Xiao-Jing Zhang, Ying-Ping Xue, Lei Huang, Fu-Dong Shi, Guo-Yan Qi   +11 more
doaj   +1 more source

Takotsubo syndrome in patients with myasthenia gravis: a systematic review of previously reported cases

BMC Neurology, 2019
Background Myasthenia gravis associated takotsubo syndrome is a rare condition. This study aimed to explore its typical presentation, investigations and treatment through a systematic review of previously reported cases.
Devarajan Rathish, Minuri Karalliyadda
doaj   +1 more source

Design of and Early Insights From a Generalized Myasthenia Gravis Patient Engagement Research Council

Health Science Reports
Background and Aims An exploratory focus group study was conducted to better understand the needs of patients living with generalized myasthenia gravis (gMG).
Gabrielle Geonnotti, Jacqueline Pesa, Wesley Peters, Melina Taylor, Zia Choudhry, Oluyemisi Falope, Marquetta Price, Lucy Baxter, Bruce West, Lisa Shea   +9 more
doaj   +1 more source

Myasthenia Gravis [PDF]

The Journal of Nervous and Mental Disease, 1902
n ...
openaire   +1 more source

Dental Care in Patients with Myasthenia Gravis

Česká Stomatologie a Praktické Zubní Lékařství, 2010
Myasthenia gravis is an autoimmune disease in the neuromuscular transmission, causing muscular weakness and fatique especially in the facial and pharyngeal muscles.
J. Piťha
doaj  

Statin-associated weakness in myasthenia gravis: a case report

Journal of Medical Case Reports, 2010
Introduction Myasthenia gravis is a commonly undiagnosed condition in the elderly. Statin medications can cause weakness and are linked to the development and deterioration of several autoimmune conditions, including myasthenia gravis.
Keogh Michael J, Findlay John M, Leach Simon, Bowen John   +3 more
doaj   +1 more source